NAV3 copy number changes and target genes in basal and squamous cell cancers

Experimental Dermatology

Volumn 20, Issue 11, 2011, Pages 926-931

  Maliniemi, Pilvi ^a   Carlsson, Emilia ^a   Kaukola, Anna ^a   Ovaska, Kristian ^b   Niiranen, Kirsi ^a   Saksela, Olli ^a   Jeskanen, Leila ^a   Hautaniemi, Sampsa ^b   Ranki, Annamari ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Basal cell carcinoma; Neuron navigator 3; Primary epithelial keratinocytes; Squamous cell carcinoma

Indexed keywords

CYTOSKELETON PROTEIN; NEURON NAVIGATOR 3; OLIGODEOXYRIBONUCLEOTIDE; REGULATOR PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ACTINIC KERATOSIS; AGED; ARTICLE; BASAL CELL CARCINOMA; CHROMOSOME 12; CHROMOSOME 6; CHROMOSOME ABERRATION; CONTROLLED STUDY; COPY NUMBER VARIATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATINOCYTE; MALE; MELANOMA; MICROARRAY ANALYSIS; PROTEIN EXPRESSION; SKIN INFLAMMATION; SQUAMOUS CELL CARCINOMA;

AGED; AGED, 80 AND OVER; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; CELLS, CULTURED; FEMALE; GENE DOSAGE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; KERATINOCYTES; MALE; MEMBRANE PROTEINS; NERVE TISSUE PROTEINS; POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, SMALL INTERFERING; SKIN NEOPLASMS;

EID: 80054109938     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2011.01358.x     Document Type: Article

References (42)

1. Marcil I, Stern R S. Arch Dermatol 2000: 136: 1524-1530.
2. Iwasaki J K, Srivastava D, Moy R L et al. J Am Acad Dermatol 2010. DOI.
3. Saran A. Future Oncol 2010: 6: 1003-1014.
4. Wood L D, Parsons D W, Jones S et al. Science 2007: 318: 1108-1113.
5. Martinez-Lopez M J, Alcantara S, Mascaro C et al. Mol Cell Neurosci 2005: 28: 599-612.
6. Merrill R A, Plum L A, Kaiser M E et al. Proc Natl Acad Sci USA 2002: 99: 3422-3427.
7. Berzat A, Hall A. EMBO J 2010: 29: 2734-2745.
8. Karenko L, Hahtola S, Paivinen S et al. Cancer Res 2005: 65: 8101-8110.
9. Hahtola S, Burghart E, Jeskanen L et al. J Invest Dermatol 2008: 128: 2304-2309.
10. Bleeker F E, Lamba S, Rodolfo M et al. Hum Mutat 2009: 30: E451-E459.
11. Nord H, Hartmann C, Andersson R et al. Neuro Oncol 2009: 11: 803-818.
12. Coy J F, Wiemann S, Bechmann I et al. Gene 2002: 290: 73-94.
13. Soon P, Gill A, Benn D et al. Endocr Relat Cancer 2009: 16: 573-583.
14. Yatsuoka T, Furukawa T, Sunamura M et al. Oncol Rep 2004: 12: 1263-1268.
15. Yamanaka S, Sunamura M, Furukawa T et al. Lab Invest 2004: 84: 1339-1351.
16. Ovaska K, Laakso M, Haapa-Paananen S et al. Genome Med 2010: 2: 65.
17. Gertz E M, Sengupta K, Difilippantonio M J et al. BMC Genomics 2009: 10: 566.
18. Zavialov A V, Engstrom A. Biochem J 2005: 391 (Pt 1): 51-57.
19. Iijima R, Kunieda T, Yamaguchi S et al. J Biol Chem 2008: 283: 2255-2264.
20. Lee K Y, Geng H, Ng K M et al. Oncogene 2008: 27: 5267-5276.
21. Reifenberger J, Wolter M, Knobbe C B et al. Br J Dermatol 2005: 152: 43-51.
22. O'Driscoll L, McMorrow J, Doolan P et al. Mol Cancer 2006: 5: 74.
23. Herzberg A J, Garcia J A, Kerns B J et al. J Cutan Pathol 1993: 20: 216-222.
24. Fortier-Beaulieu M, Laquerriere A, Thomine E et al. Dermatology 1994: 188: 94-99.
25. Robinson J K, Rademaker A W, Goolsby C et al. Cancer 1996: 77: 284-291.
26. Hass H G, Schmidt A, Nehls O et al. Oral Oncol 2008: 44: 78-85.
27. Casalone R, Mazzola D, Righi R et al. Cancer Genet Cytogenet 2000: 118: 136-143.
28. Nangia R, Sait S N, Block A W et al. Cancer 2001: 91: 1927-1932.
29. Akhmanova A, Hoogenraad C C. Curr Opin Cell Biol 2005: 17: 47-54.
30. van Haren J, Draegestein K, Keijzer N et al. Cell Motil Cytoskeleton 2009: 66: 824-838.
31. Yang D, Thangaraju M, Browning D D et al. J Immunol 2007: 179: 4775-4782.
32. Aguilar-Rojas A, Huerta-Reyes M. Oncol Rep 2009: 22: 981-990.
33. Hafner C, Landthaler M, Vogt T. Exp Dermatol 2010: 19: 222-227.
34. Ghali L, Wong S T, Green J et al. J Invest Dermatol 1999: 113: 595-599.
35. Tojo M, Kiyosawa H, Iwatsuki K et al. Br J Dermatol 2003: 148: 892-897.
36. Laner-Plamberger S, Kaser A, Paulischta M et al. Oncogene 2009: 28: 1639-1651.
37. Liu Z L, Li Y, Kong Q Y et al. J Dermatol Sci 2008: 52: 133-136.
38. Teh M T, Blaydon D, Ghali L R et al. J Cell Sci 2007: 120 (Pt 2): 330-339.
39. Barker N. Methods Mol Biol 2008: 468: 5-15.
40. Stringham E G, Schmidt K L. Cell Adh Migr 2009: 3: 342-346.
41. Dijkgraaf G J, Alicke B, Weinmann L et al. Cancer Res 2010: 71: 435-444.
42. Hyytinen E, Visakorpi T, Kallioniemi A et al. Cytometry 1994: 16: 93-99.